CXCL13 and rheumatoid arthritis: DEGs like CXCL13, CD247, GZMB, CCL18, IL7R, and ADAMDEC1, identified by Kang et al. and validated by Li et al., reveal molecular distinctions between RA and OA, offering more precise diagnostic and therapeutic targets [92].